Competitive Intelligence for Healthcare and healthtech
Competitive intelligence for healthtech — clinical-trial, regulation, and partnership signals.
Healthtech CI requires tracking clinical-trial registrations, FDA submissions, payer contracts, and provider-system partnerships alongside the standard signal set. RivalBeam covers it.
The healthcare and healthtech CI job
Healthtech CI exists to inform clinical strategy (which competitor is running which trials?), payer/provider strategy (who has signed which contracts?), and regulatory positioning (which FDA pathways are they pursuing?).
Signal sources that matter for healthcare and healthtech
RivalBeam pulls all 6 of these public channels (plus 9 more) and synthesizes them into AI-written briefs.
ClinicalTrials.gov registrations
competitor trial registrations signal product-development priority and the patient population they're chasing
FDA submissions (510k, PMA, De Novo)
regulatory pathway selection signals risk tolerance and timeline
Health-system partnership announcements
named-account wins with Epic-EHR systems, large IDNs, and payer integrations signal commercial momentum
Conference presence (HIMSS, JPM, ACR, RSNA)
exhibit booth size, presentation count, and panel placement signal positioning investment
Publication activity (PubMed, peer-reviewed journals)
clinical-evidence publication is the slowest-but-most-fatal competitive signal in healthcare
Reimbursement / coding changes
new CPT codes, payer policy changes, and Medicare coverage decisions are massive market expansions or contractions
The healthcare and healthtech battlecard
RivalBeam auto-populates these fields from the signal feed. Battlecards stay current without manual updates.
- → Regulatory clearance status
- → Top 3 clinical trial outcomes
- → Reimbursement landscape (CPT codes covered)
- → Health-system partnerships (named accounts)
- → Patient-population fit
- → Top 3 published efficacy claims
- → Pricing model (per-procedure vs subscription vs value-based)
What not to do in healthcare and healthtech CI
- Treating healthcare CI like B2B SaaS CI (regulatory and clinical signals dominate; product-feature signals are secondary)
- Ignoring publication cadence (peer-reviewed evidence is the slowest-but-most-durable competitive moat)
- Skipping payer-policy tracking (a reimbursement change can collapse or expand a competitor's TAM overnight)
- Underweighting the conference signal (HIMSS booth size correlates strongly with commercial momentum in healthtech)
Common competitor archetypes in healthcare and healthtech
- The well-funded Series B-C health-tech (Andreessen / GV / 7wireVentures-backed)
- The established medical-device company moving digital
- The big-tech entrant (Amazon, Apple, Google healthcare arms)
- The international entrant from EU/UK regulatory frameworks
- The clinical-stage competitor without product yet
Frequently asked
Does RivalBeam handle ClinicalTrials.gov tracking?▾
Yes — we monitor competitor trial registrations, status changes, and posted results. Briefs synthesize: 'Competitor X registered a Phase 2 trial in obesity, target enrollment 400, primary endpoint at 24 weeks — this aligns with their stated 2026 launch timeline.'
How does this compare to healthtech-specific tools?▾
Dedicated healthtech intelligence (Definitive Healthcare, Komodo Health) focus on provider/claim data at $50-200K/yr. RivalBeam complements with the operational signals (clinical trials, FDA, partnerships, conference) that those platforms don't cover well.
Pricing for a healthtech team?▾
Pro ($399/mo) — healthtech CI needs the deeper data coverage + audit logs that the Pro tier provides. Some compliance frameworks (HITRUST, SOC 2) require audit-log retention.
Ready to ship healthcare and healthtech CI?
Pro tier ($399/mo) recommended — includes audit logs + Salesforce/Teams · 14-day free trial · No credit card.
CI for other verticals